Clinical Trial Detail

NCT ID NCT01169636
Title Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

Hodgkin's lymphoma

Therapies

Panobinostat

Pegfilgrastim

Carboplatin + Etoposide + Ifosfamide

Age Groups: child adult

No variant requirements are available.